Ten (71%) of the 14 patients were consistently positive for ApoA-1 IgG, five (83%) out of the six patients with HCV genotype 1 infection (Fig. 1a) and five (63%) out of the eight patients with HCV genotype 3 infection (Fig. 1b). This evidence concerns the gene APOA1 and infection.